The LINQ II ICM is the first continuous, long-term cardiac monitor cleared by FDA for the pediatric patient population The LINQ II system is a small (one-third the size of a AAA battery), wireless ICM ...

MOBILE, Ala. (WALA) -The FDA recently expanded use for the LINQ II™ insertable cardiac monitor (ICM) to patients ages 2 years and older who have heart rhythm issues. About one-third the size of a AAA ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

The U.S. Food and Drug Administration gave Minneapolis-based Medtronic 510(k) clearance for its Reveal LINQ Insertable Cardiac Monitoring system, according to a news release. At one-third the size of ...

(RTTNews) - Medtronic plc (MDT) announced the LINQ II Insertable Cardiac Monitor system is the first-and-only ICM to receive 510(k) clearance by the FDA for use in pediatric patients over the age of 2 ...

Medtronic developed a way to reduce false alerts through its AccuRhythm™ AI algorithms. The algorithm is applied through cloud-based updates to all LINQ II™ Insertable Cardiac Monitors (ICMs) and ...

Kymberli Petronio talks about her health journey and what led to her diagnosis and her son's diagnosis and what this long-term heart monitor means for patients and ...

Please provide your email address to receive an email when new articles are posted on . Remote reprogramming for implantable cardiac devices was associated with an improvement in clinic workflow.

Medtronic said its AccuRhythm AI algorithm technology is the winner of the 7 th annual MedTech Breakthrough Awards program as the "Best New Monitoring Solution." AccuRhythm AI is an artificial ...

ISC23: Late-breaking results from STROKE AF study reinforce importance of long-term continuous cardiac monitoring in ischemic stroke patients Over the first year, 12.5%* of patients in the ICM arm had ...